Current and emerging therapies for rheumatoid arthritis, with a focus on infliximab: clinical impact on joint damage and cost of care in Canada
Anthony Russell, Boulos Haraoui, Edward Keystone, Alice KlinkhoffVolume:
23
Year:
2001
Language:
english
DOI:
10.1016/s0149-2918(00)80079-x
File:
PDF, 761 KB
english, 2001